Part detail
Felodipine Extended Release Tabl
NDC00603-3583-21NSN6505-01-350-0355CAGE0VZ12
Felodipine Extended Release Tabl
Detailed description
NDC00603-3583-21 procurement notes
Felodipine Extended Release Tabl
Specifications
Reference data
Multi-line procurement
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
Compliance
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
Characteristics Data of NSN 6505-01-350-0355, 6505013500355
| MRC | Criteria | Characteristic |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | FELODIPINE EXTENDED RELEASE TABLETS 10MG 100S BT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10 000 MILLIGRAMS FELODIPINE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CBBL | FEATURES PROVIDED | CHILD RESISTANT CLOSURE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100 000 TABLETS |
| FEAT | SPECIAL FEATURES | STORE AT 20-25 DEG C68-77 DEG FEXCURIONS PERMITTED TO 15-30 DEG C 59-86 DEG F SEE USP CONTROLLED ROOM TEMPERATURE |
